Shares in Pfizer (NYSE:PFE) fell today after the pharma giant missed sales expectations, but beat earnings estimates on Wall Street with its 1st quarter results. The N.Y.-based company posted profits of $3.12 billion, or 51¢ per share, on sales of $12.78 billion for the 3 months ended March 31, for bottom-line growth of 3% on sales loss […]
ICU Medical
Hospira, Baxter subpoenaed in antitrust probe over intravenous saline
Drugmakers received grand jury subpoenas from the U.S. Justice Dept. this week in connection with an antitrust probe into companies that market intravenous saline solutions. ICU Medical (NSDQ:ICUI), which recently acquired Hospira Infusion Systems from Pfizer (NYSE:PFE), and Baxter (NYSE:BAX) disclosed the subpoenas this week. Pfizer revealed that it is also wrapped up in the investigation, according […]
ICU Medical touts dosing errors study
ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira (NYSE:HSP) MedNet safety software were integrated with the hospitals’ electronic medical records. The rate of potentially catastrophic dosing errors fell by 52% after smart-pump EMR integration, the study found, […]